Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1989 Oct;65(768):743–747. doi: 10.1136/pgmj.65.768.743

Giant cell arteritis: difficult decisions in diagnosis, investigation and treatment.

E W Paice 1
PMCID: PMC2429811  PMID: 2694137

Full text

PDF
743

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison M. C., Gallagher P. J. Temporal artery biopsy and corticosteroid treatment. Ann Rheum Dis. 1984 Jun;43(3):416–417. doi: 10.1136/ard.43.3.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allison M. C., Gough K. R. Steroid sensitive systemic disease with anaemia in the elderly: a manifestation of giant cell arteritis? Postgrad Med J. 1985 Jun;61(716):501–503. doi: 10.1136/pgmj.61.716.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Andersson R., Malmvall B. E., Bengtsson B. A. Acute phase reactants in the initial phase of giant cell arteritis. Acta Med Scand. 1986;220(4):365–367. doi: 10.1111/j.0954-6820.1986.tb02779.x. [DOI] [PubMed] [Google Scholar]
  4. Andersson R., Malmvall B. E., Bengtsson B. A. Long-term corticosteroid treatment in giant cell arteritis. Acta Med Scand. 1986;220(5):465–469. doi: 10.1111/j.0954-6820.1986.tb02796.x. [DOI] [PubMed] [Google Scholar]
  5. Andersson R., Malmvall B. E., Bengtsson B. A. Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids. Acta Med Scand. 1986;220(4):361–364. doi: 10.1111/j.0954-6820.1986.tb02778.x. [DOI] [PubMed] [Google Scholar]
  6. Behn A. R., Perera T., Myles A. B. Polymyalgia rheumatica and corticosteroids: how much for how long? Ann Rheum Dis. 1983 Aug;42(4):374–378. doi: 10.1136/ard.42.4.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Boyd R. V., Hoffbrand B. I. Erythrocyte sedimentation rate in elderly hospital in-patients. Br Med J. 1966 Apr 9;1(5492):901–902. doi: 10.1136/bmj.1.5492.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Caselli R. J., Hunder G. G., Whisnant J. P. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology. 1988 Mar;38(3):352–359. doi: 10.1212/wnl.38.3.352. [DOI] [PubMed] [Google Scholar]
  9. Chuang T. Y., Hunder G. G., Ilstrup D. M., Kurland L. T. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982 Nov;97(5):672–680. doi: 10.7326/0003-4819-97-5-672. [DOI] [PubMed] [Google Scholar]
  10. De Silva M., Hazleman B. L. Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis. 1986 Feb;45(2):136–138. doi: 10.1136/ard.45.2.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Delecoeuillerie G., Joly P., Cohen de Lara A., Paolaggi J. B. Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis. 1988 Sep;47(9):733–739. doi: 10.1136/ard.47.9.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Doury P., Fabresse F. X., Pattin S., Eulry F., Celton H., Larroque P. La place de la dapsone dans le traitement de la maladie de Horton et de la pseudopolyarthrite rhizomélique. Ann Med Interne (Paris) 1984;135(1):31–35. [PubMed] [Google Scholar]
  13. Ellis M. E., Ralston S. The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis. 1983 Apr;42(2):168–170. doi: 10.1136/ard.42.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Eshaghian J., Goeken J. A. C-reactive protein in giant cell (cranial, temporal) arteritis. Ophthalmology. 1980 Nov;87(11):1160–1166. doi: 10.1016/s0161-6420(80)35110-5. [DOI] [PubMed] [Google Scholar]
  15. Graham E., Holland A., Avery A., Russell R. W. Prognosis in giant-cell arteritis. Br Med J (Clin Res Ed) 1981 Jan 24;282(6260):269–271. doi: 10.1136/bmj.282.6260.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Greene G. M., Lain D., Sherwin R. M., Wilson J. E., McManus B. M. Giant cell arteritis of the legs. Clinical isolation of severe disease with gangrene and amputations. Am J Med. 1986 Oct;81(4):727–733. doi: 10.1016/0002-9343(86)90568-1. [DOI] [PubMed] [Google Scholar]
  17. Hall S., Hunder G. G. Is temporal artery biopsy prudent? Mayo Clin Proc. 1984 Nov;59(11):793–796. doi: 10.1016/s0025-6196(12)65593-1. [DOI] [PubMed] [Google Scholar]
  18. Hall S., Persellin S., Lie J. T., O'Brien P. C., Kurland L. T., Hunder G. G. The therapeutic impact of temporal artery biopsy. Lancet. 1983 Nov 26;2(8361):1217–1220. doi: 10.1016/s0140-6736(83)91269-2. [DOI] [PubMed] [Google Scholar]
  19. Healey L. A., Wilske K. R. Presentation of occult giant cell arteritis. Arthritis Rheum. 1980 Jun;23(6):641–643. doi: 10.1002/art.1780230605. [DOI] [PubMed] [Google Scholar]
  20. Hunder G. G., Sheps S. G., Allen G. L., Joyce J. W. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study. Ann Intern Med. 1975 May;82(5):613–618. doi: 10.7326/0003-4819-82-5-613. [DOI] [PubMed] [Google Scholar]
  21. Jacobson D. M., Slamovits T. L. Erythrocyte sedimentation rate and its relationship to hematocrit in giant cell arteritis. Arch Ophthalmol. 1987 Jul;105(7):965–967. doi: 10.1001/archopht.1987.01060070101037. [DOI] [PubMed] [Google Scholar]
  22. Jonasson F., Cullen J. F., Elton R. A. Temporal arteritis. A 14-year epidemiological, clinical and prognostic study. Scott Med J. 1979 Apr;24(2):111–117. doi: 10.1177/003693307902400203. [DOI] [PubMed] [Google Scholar]
  23. Karacostas D., Taskos N., Tsounis S., Nikolaides T. CT findings in temporal arteritis. A report of two cases. Neuroradiology. 1986;28(4):373–373. doi: 10.1007/BF00333451. [DOI] [PubMed] [Google Scholar]
  24. Karam G. H., Fulmer J. D. Giant cell arteritis presenting as interstitial lung disease. Chest. 1982 Dec;82(6):781–784. doi: 10.1378/chest.82.6.781. [DOI] [PubMed] [Google Scholar]
  25. Klein R. G., Hunder G. G., Stanson A. W., Sheps S. G. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med. 1975 Dec;83(6):806–812. doi: 10.7326/0003-4819-83-6-806. [DOI] [PubMed] [Google Scholar]
  26. Kramer M. R., Melzer E., Nesher G., Sonnenblick M. Pulmonary manifestations of temporal arteritis. Eur J Respir Dis. 1987 Nov;71(5):430–433. [PubMed] [Google Scholar]
  27. Ladanyi M., Fraser R. S. Pulmonary involvement in giant cell arteritis. Arch Pathol Lab Med. 1987 Dec;111(12):1178–1180. [PubMed] [Google Scholar]
  28. Larson T. S., Hall S., Hepper N. G., Hunder G. G. Respiratory tract symptoms as a clue to giant cell arteritis. Ann Intern Med. 1984 Nov;101(5):594–597. doi: 10.7326/0003-4819-101-5-594. [DOI] [PubMed] [Google Scholar]
  29. Lipton R. B., Rosenbaum D., Mehler M. F. Giant cell arteritis causes recurrent posterior circulation transient ischemic attacks which respond to corticosteroid. Eur Neurol. 1987;27(2):97–100. doi: 10.1159/000116139. [DOI] [PubMed] [Google Scholar]
  30. Mallya R. K., Hind C. R., Berry H., Pepys M. B. Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study. Arthritis Rheum. 1985 Apr;28(4):383–387. doi: 10.1002/art.1780280405. [DOI] [PubMed] [Google Scholar]
  31. Olhagen B. Polymyalgia rheumatica. Clin Rheum Dis. 1986 Apr;12(1):33–47. [PubMed] [Google Scholar]
  32. Paice E. W., Wright F. W., Hill A. G. Sternoclavicular erosions in polymyalgia rheumatica. Ann Rheum Dis. 1983 Aug;42(4):379–383. doi: 10.1136/ard.42.4.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Perruquet J. L., Davis D. E., Harrington T. M. Aortic arch arteritis in the elderly. An important manifestation of giant cell arteritis. Arch Intern Med. 1986 Feb;146(2):289–291. [PubMed] [Google Scholar]
  34. Schreiber S. CRP in the management of polymyalgia rheumatica and giant cell arteritis. Clin Rheumatol. 1987 Mar;6(1):97–98. doi: 10.1007/BF02201011. [DOI] [PubMed] [Google Scholar]
  35. Strachan R. W., How J., Bewsher P. D. Masked giant-cell arteritis. Lancet. 1980 Jan 26;1(8161):194–196. doi: 10.1016/s0140-6736(80)90675-3. [DOI] [PubMed] [Google Scholar]
  36. Vilaseca J., González A., Cid M. C., Lopez-Vivancos J., Ortega A. Clinical usefulness of temporal artery biopsy. Ann Rheum Dis. 1987 Apr;46(4):282–285. doi: 10.1136/ard.46.4.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wendling D., Hory B., Blanc D. Cyclosporine: a new adjuvant therapy for giant cell arteritis? Arthritis Rheum. 1985 Sep;28(9):1078–1079. doi: 10.1002/art.1780280921. [DOI] [PubMed] [Google Scholar]
  38. Wilske K. R., Healey L. A. Polymyalgia rheumatica and giant cell arteritis. The dilemma of therapy. Postgrad Med. 1985 Jun;77(8):243–248. doi: 10.1080/00325481.1985.11699042. [DOI] [PubMed] [Google Scholar]
  39. Wong R. L., Korn J. H. Temporal arteritis without an elevated erythrocyte sedimentation rate. Case report and review of the literature. Am J Med. 1986 May;80(5):959–964. doi: 10.1016/0002-9343(86)90645-5. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES